Want to join the conversation?
Medical devices company $TFX said the results of its pre-clinical intravascular study highlighted Arrow PICC with Chlorag ard Technology and its ability to significantly reduce thrombus formation when compared to competitive non-eluting antithrombogenic technologies. The eluting technology showed the best outcomes after a 30-day dwell time.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.